| |
| |
|
| Insider
Information: |
Erck Stanley C |
| Relationship: |
President and CEO, Dir... |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
84,825 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$228,201 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
84,825 |
|
|
| Total
Value |
$228,201 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -200.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2018-11-28 |
48,333 |
2009-03-12 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
President and CEO, Dir... |
2022-12-14 |
36,492 |
2011-08-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
– • – |
2009-03-12 |
4 |
B |
$1.22 |
$48,880 |
D/D |
40,000 |
40,000 |
2.39 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2018-11-28 |
4 |
OE |
$1.49 |
$12,416 |
D/D |
8,333 |
48,333 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2011-08-09 |
4 |
B |
$1.24 |
$41,476 |
D/D |
33,448 |
33,448 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2011-08-10 |
4 |
B |
$1.24 |
$20,524 |
D/D |
16,552 |
16,552 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2011-08-19 |
4 |
B |
$1.26 |
$16,380 |
D/D |
13,000 |
13,000 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2014-01-31 |
4 |
B |
$2.29 |
$27,178 |
D/D |
11,868 |
74,868 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
CEO and President |
• • – |
2014-03-25 |
4/A |
B |
$4.27 |
$42,698 |
D/D |
10,000 |
84,868 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
CEO and President |
• • – |
2014-03-25 |
4 |
S |
$4.27 |
$42,698 |
D/D |
(10,000) |
84,868 |
0 |
- |
|
| NVAX |
Novavax Inc |
CEO and President |
• • – |
2014-07-31 |
4 |
B |
$2.28 |
$15,477 |
D/D |
6,788 |
91,656 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
CEO and President |
• • – |
2015-01-31 |
4 |
B |
$2.28 |
$13,958 |
D/D |
6,122 |
97,778 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
CEO and President |
• • – |
2015-07-31 |
4 |
B |
$2.28 |
$7,312 |
D/D |
3,207 |
100,985 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
CEO and President |
• • – |
2016-01-31 |
4 |
B |
$4.38 |
$9,075 |
D/D |
2,072 |
103,057 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2016-03-30 |
4 |
S |
$5.19 |
$1,028,003 |
D/D |
(198,009) |
103,057 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2016-03-30 |
4 |
OE |
$1.28 |
$253,452 |
D/D |
198,009 |
301,066 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2016-03-31 |
4 |
S |
$5.18 |
$1,175,616 |
D/D |
(226,769) |
78,279 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2016-03-31 |
4 |
OE |
$1.28 |
$258,548 |
D/D |
201,991 |
305,048 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2017-05-11 |
4 |
B |
$0.84 |
$41,980 |
D/D |
50,000 |
128,279 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2017-11-09 |
4 |
B |
$1.13 |
$113,050 |
D/D |
100,000 |
228,279 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2018-05-14 |
4 |
B |
$1.65 |
$164,620 |
D/D |
100,000 |
328,279 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,072 |
22,486 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-03-08 |
4 |
D |
$12.48 |
$24,860 |
D/D |
(1,992) |
20,494 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-09-26 |
4 |
D |
$113.56 |
$276,405 |
D/D |
(2,434) |
24,606 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,546 |
27,040 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-09-28 |
4 |
D |
$111.18 |
$148,759 |
D/D |
(1,338) |
73,268 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-09-28 |
4 |
OE |
$5.95 |
$297,500 |
D/D |
50,000 |
74,606 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
